Infliximab in neurosarcoidosis: a systematic review and meta-analysis.

Objectives: To evaluate the clinical outcomes and relapse rates in neurosarcoidosis patients administered infliximab.

Methods: A systematic review was conducted using the MEDLINE, EMBASE, SCOPUS, and Cochrane Library databases. The search included studies from their inception to March 2023.

Familial neuromyelitis optica spectrum disorders: Case series and systematic review.

Background: Neuromyelitis optica spectrum disorders (NMOSD) is considered a complex multifactorial disorder. Most cases are sporadic, and familial NMOSD is assumed as a rare occurrence. However, few studies reported familial aggregation of the disorder.